Boehringer Ingelheim launches AI centre for pharma research in London | The Mighty 790 KFGO
Boehringer Ingelheim launches AI centre for pharma research in London | The Mighty 790 KFGO
https://kfgo.com/2026/04/20/boehringer-ingelheim-launches-ai-centre-for-pharma-research-in-london/
Publish Date: 2026-04-20 15:16:00
Source Domain: kfgo.com
- Boehringer Ingelheim is opening a new AI and machine learning centre in London, expanding its AI capabilities in pharmaceutical R&D.
- The organisation is focusing its efforts on developing targeted medicines for patients with unmet medical needs.
- Boehringer Ingelheim plans to invest £150 million ($200 million) over a 10-year period for this new centre.
- The centre aims to leverage advanced computing methods like algorithms, data analysis, and AI to streamline and accelerate the drug discovery process.
- The UK’s commitment to data-driven innovation in life sciences and healthcare, along with its strong legacy in AI, was a key factor in selecting London as the location for this new facility.
